Finance

Beta
Lists
6951:TYO
JEOL Ltd
Â¥7,320.00
+0.05%
(+4.00) 1D
Jun 4, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 6951...
Open
Â¥7,300
High
Â¥7,356
Low
Â¥7,237
Mkt. cap
377.22B
Avg. vol.
433.48K
Volume
356.60K
Dividend
1.80%
Quarterly dividend
Â¥33
Ex-dividend date
Mar 30, 2026
P/E ratio
16.92
52-wk high
Â¥7,475
52-wk low
Â¥4,044
EPS
Â¥433
Shares outstanding
48.31M
No. of employees
4K
Open
Â¥7,300
High
Â¥7,356
Low
Â¥7,237
Mkt. cap
377.22B
Avg. vol.
433.48K
Volume
356.60K
Dividend
1.80%
Quarterly dividend
Â¥33
Ex-dividend date
Mar 30, 2026
P/E ratio
16.92
52-wk high
Â¥7,475
52-wk low
Â¥4,044
EPS
Â¥433
Shares outstanding
48.31M
No. of employees
4K
News stories
From sources across the web
Profile
JEOL, Ltd. is a major developer and manufacturer of electron microscopes and other scientific instruments, industrial equipment and medical equipment. Its headquarters are in Tokyo, Japan, with 25 domestic and foreign subsidiaries and associated companies as of 2014. It is listed in the top ten businesses worldwide for analytical laboratory instrument manufacturing. JEOL's instruments are used by researchers around the world, including the University of Cambridge, University of Oxford, and MIT. It has been included in the Activest Lux Nanotech Mutual Fund and the WestLB Nanotech Fund. Wikipedia
About JEOL Ltd
CEOGonemon Kurihara
Employees3.6K
FoundedMay 30, 1949
HeadquartersAkishima, Tokyo, Japan
SectorComputer hardware
Websitejeol.co.jp
Last report
May 15, 2026
Fiscal period
Q4 2026
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
49.55B / 51.31B
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
40.14B
41.91B
47.74B
49.55B
Cost of goods sold
20.69B
22.09B
24.73B
28.81B
Cost of revenue
20.69B
22.09B
24.73B
28.81B
Research and development expenses
3.14B
2.81B
2.65B
2.80B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
21.40B
-21.40B
45.61B
Operating expense
13.66B
13.68B
13.55B
16.12B
Total operating expenses
34.35B
35.77B
38.28B
44.93B
Operating income
5.79B
6.14B
9.46B
4.62B
Other non operating income
153.00M
216.00M
96.00M
-128.00M
EBT including unusual items
6.76B
7.13B
10.80B
4.80B
EBT excluding unusual items
5.78B
7.12B
10.75B
4.96B
Income tax expense
2.10B
1.95B
3.16B
192.00M
Effective tax rate
30.97%
27.30%
-
4.00%
Other operating expenses
10.52B
-10.52B
32.29B
-32.29B
Net income
4.67B
5.18B
7.64B
4.61B
Net profit margin
11.63%
12.36%
-
9.30%
Earnings per share
-
-
-
-
Interest and investment income
135.00M
91.00M
155.00M
120.00M
Interest expense
-22.00M
-22.00M
-27.00M
-62.00M
Net interest expenses
113.00M
69.00M
128.00M
58.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
7.41B
10.76B
6.00B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer